Search
Filter Results
Displaying 721–730 of 896 results for “vision connection”
-
Speakers joining the Foundation Fighting Blindness for the United in Vision 2026 conference.
-
May 5, 2026
Two Twins, One Rare Diagnosis, and a Family Holding on to Hope
Invisible DisabilityRaising two twins with the same rare condition comes with challenges that many people cannot see. Everyday tasks often require extra patience, planning, and support. Our twins may experience the world differently, but they face it with courage every day.
-
Apr 22, 2026
In the PressFour-year cohort will enroll participants with inherited retinal diseases caused by mutations in the RHO gene. Study is intended to deepen understanding of disease progression and inform future clinical trial design in rhodopsin-associated retinal disease.
-
Apr 21, 2026
Atsena Therapeutics Advances to Pivotal Phase 3 Trial for X-Linked Retinoschisis
Research NewsData monitoring committee recommends proceeding with registration-enabling study for ATSN-201
-
Feb 27, 2026
Eye on the Cure Podcast | Episode 100: BEST OF
Eye on the CureCelebrating 100 episodes of conversations about groundbreaking research and fascinating journeys with vision loss.
-
Feb 6, 2026
Eye on the Cure Podcast | Episode 99: Dr. Prem Subramanian
Eye on the CureDr. Subramanian discusses thyroid eye disease (TED), its potential causes, symptoms, and therapeutic approaches.
-
Jan 16, 2026
AAVantgarde Completes Enrollment in Retinal Gene Therapy Trial for Usher Syndrome Type 1B
Research NewsMilestone brings hope to patients with rare inherited retinal disease
-
Jan 13, 2026
Research NewsFirst patient treated in Part B of ASTRA trial evaluating SB-007.
-
Dec 19, 2025
Eye on the Cure Podcast | Episode 97: Lindsey Rambo
Eye on the CureA mom, wife, and a special education teaching assistant, Lindsey is the first participant in a groundbreaking gene therapy trial for Leber congenital amaurosis (LCA5).
-
Dec 18, 2025
Beacon Therapeutics Launches Clinical Trial for Bilateral Administration of XLRP Gene Therapy
Research NewsThe company has also fully enrolled the Phase 2/3 VISTA clinical trial for its XLRP gene therapy.